OPKO Health | OPK - Selling And Administration Expenses

Stock Price
455.90
Daily Change
1.60 0.35%
Monthly
6.32%
Yearly
-22.33%
Q3 Forecast
457.27

OPKO Health reported $59.6M in Selling and Administration Expenses for its fiscal quarter ending in June of 2025.



Financials
Stock Price USD
Assets USD 1.97B
Cash and Equivalent USD 267.28M
Cost of Sales USD 137.75M
Current Assets USD 583.33M
Current Liabilities USD 171.18M
Debt USD 395.74M
EBIT USD -92.19M
EBITDA USD -69.17M
Employees USD 3.93K
EPS Earnings Per Share USD -0.19
Equity Capital and Reserves USD 1.3B
Gross Profit on Sales USD 19.06M
Interest Expense on Debt USD 70.33M
Interest Income USD 3.29M
Loan Capital USD 332.94M
Market Capitalization USD 3.18B
Net Income USD -148.44M
Operating Expenses USD 216.79M
Operating Profit USD -59.98M
Ordinary Share Capital USD 779.78M
PE Price to Earnings USD 40.77
Pre-Tax Profit USD -162.52M
Sales Revenues USD 156.81M
Selling and Administration Expenses USD 59.6M
Stock USD 66.34M
Trade Creditors USD 56.68M
Trade Debtors USD 110.19M

Selling And Administration Expenses Change Date
Alcidion AUD 13.85M 6.34M Dec/2024
Ambu A/S DKK 630M 0 Jun/2025
Apollo Hospitals Enterprise Ltd 7.25B 382M Mar/2025
Convatec Group 420.3M 210.35M Dec/2024
Diasorin EUR 81.89M 21.11M Jun/2025
Gulf Medical Proj AED 29.91M 1.27M Mar/2025
Ionis Pharmaceuticals USD 90.6M 14.6M Jun/2025
Med Life RON 25.65M 158.01M Dec/2024
OPKO Health USD 59.6M 7.4M Jun/2025
Oriola-kd EUR 16.1M 2M Jun/2025
Rede D'or Sao Luiz BRL 541.91M 133.12M Jun/2025
Siemens Healthineers EUR 947M 44M Jun/2025
Sonova Holding CHF 879.9M 48.8M Sep/2024